Mohammad Hossein Sanei
1 , Maryam Malekmohammad
2* , Maryam Sanei
3 1 Department of Pathology, School of Medicine, Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Medical Student, Isfahan University of Medical Sciences, Isfahan, Iran
Keywords: Colorectal cancer, CD44, Survival, Prognostic marker, Metastasis